International researchers summarize the current understanding of peptic disease and trace the development of a novel new drug for peptic
disease therapy-sucralfate. Contributors present
laboratory research along side data from clinical trials as well as from the practice of medicine. Articles discuss the history of sucralfate's development, mechanisms of action, clinical efficacy, and future
directions for research. This volume will be of interest to scientists and clinicians working in gastroenterology and gastrointestinal physiology.
